NCT07670403Withdrawn
Digital Phenotyping of Psychological Distress in Skin Cancer Patients
Digital Phenotyping of Psychological Distress in Skin Cancer Patients: A Transformer-Based Analysis of Chinese Social Media Content
Source: ClinicalTrials.gov · Last updated 16 Oct 2026
Brief summary (registry, in English)
This prospective observational study enrolls 500 skin cancer patients across five Chinese tertiary care centers. The investigators use natural language processing and a hierarchical transformer model to analyse 1.2 million social media posts (Weibo, Douyin, Xiaohongshu, WeChat) for psychological distress and suicide ideation, with prospective validation of an AI Early Warning System.
- Status (registry)
- Withdrawn
- Study type
- Observational
- Enrollment
- 0 (actual)
- First submitted
- 17 Jun 2026
- Start date
- 1 Jan 2024
- Primary completion date
- 30 Dec 2025
- Lead sponsor
- West China Hospital
- Diseases
- Head and neck cancer, Melanoma
- NCT number
- NCT07670403
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Pre-existing major psychiatric disorder diagnosed prior to cancer diagnosis
- Concurrent participation in other digital mental health interventions
Other illness
- Cognitive impairment preventing informed consent
Other
- Inability to access social media accounts
Who the study is looking for
- Age ≥ 18 years
- Histologically confirmed skin cancer within the preceding 60 months
- Active user of at least one target social media platform (Weibo, Douyin, Xiaohongshu, or WeChat Channels)
- Willingness to provide informed consent for social media data collection
- Ability to read and write in Chinese
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| West China Hospital of Sichuan University Coordinator of this site? Confirm its status | Chengdu | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.